Quantcast

STAAR Surgical Announces Fourth Quarter 2013 Results Release Date, Conference Call And Webcast - Valley News Live - KVLY/KXJB - Fargo/Grand Forks

STAAR Surgical Announces Fourth Quarter 2013 Results Release Date, Conference Call And Webcast

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE STAAR Surgical Company

MONROVIA, Calif., Feb. 14, 2014 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it will release its financial results for the fourth quarter ended January 3, 2014 on Wednesday, February 26, 2014 after the market close.

STAAR will host a conference call and webcast on Wednesday, February 26 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss these results and recent corporate developments. The dial-in number for the conference call is 877-415-3181 for domestic participants and 857-244-7324 for international participants, both using the passcode 88698954.  The Company will also be using slides to illustrate its fourth quarter results and operational progress including comments regarding the postponed FDA panel on the TICL. The slides and live webcast of the call can be accessed from the investor relations section of the STAAR website at www.staar.com.  

A taped replay of the conference call will also be available beginning approximately one hour after the call's conclusion and will be available for seven days.  This replay can be accessed by dialing 888-286-8010 for domestic callers and 617-801-6888 for international callers, both using passcode 45739769.  An archived webcast will also be available at www.staar.com.

About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye and delivery systems therefor. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or "ICL." A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL." Over 400,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com. STAAR has approximately 300 full time employees and markets lenses in over 60 countries. Headquartered in Monrovia, CA, it manufactures in the following locations: Nidau, Switzerland; Aliso Viejo, CA; and Monrovia, CA. For more information, please visit the Company's website at www.staar.com

Collamer® is the registered trademark for STAAR's proprietary biocompatible collagen copolymer lens material. 

CONTACT:

Investors

Media


EVC Group

EVC Group


Doug Sherk, 415-652-9100 

Nicole Kruse


Leigh Salvo, 415-568-9348

212-850-6025

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
Powered by 

WorldNowAll content © Copyright 2000 - 2014 WorldNow and Valley News Live. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.